As part of the nationwide trend of precision medicine, Baylor’s Human Genome Sequencing Center will assist in sequencing the DNA of 69 different genes that may influence how patients react to certain drugs. Such pharmacogenomic findings could then be placed in patients’ medical records, providing early warnings to clinicians about which drugs may present problems for patients.
“This collaboration is a wonderful example of how a partnership between a genome center and a premier clinical group can speed the translation of valuable genomic tests into useful advances in patient care,” said Richard Gibbs, PhD, director of the Human Genome Sequencing Center at Baylor.
More articles on genomics:
Geisinger opens Precision Health Center
What do genomics mean for the individual patient?
Rare Genomics Institute announces new director and CEO
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
